NCT03141268 (RapidoIBS) is a clinical trial of Lactulose breath test in Oro-cecal Transit Time, sponsored by Uppsala University.

Who is sponsoring NCT03141268?

NCT03141268 is sponsored by Uppsala University.

What drugs are being tested in NCT03141268?

Interventions in NCT03141268: Lactulose breath test.

What condition does NCT03141268 study?

NCT03141268 studies Oro-cecal Transit Time.

Is NCT03141268 still recruiting?

NCT03141268 is currently status unknown. Last updated 9 August 2018.

Last reviewed 2018-08-09 · How we verify

NCT03141268: RapidoIBS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rapid Orocecal Transit Time and Fermentation in IBS.

Status unknown Last updated 9 August 2018

What this trial tests

trial testing Lactulose breath test in Oro-cecal Transit Time in 1,000 participants. Status unknown.

Timeline

1 January 2017

Primary endpoint
1 July 2019

1 July 2019

Quick facts

Lead sponsor	Uppsala University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 January 2017
Primary completion	1 July 2019
Estimated completion	1 July 2019
Sites	1 location across Sweden

Drugs / interventions tested

Lactulose breath test

Conditions studied

Oro-cecal Transit Time — all drugs for Oro-cecal Transit Time →

Sponsor

Uppsala University

Who can join

Adults 18 to 80, any sex, with Oro-cecal Transit Time. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Orocecal transit time is studied in individuals with irritable bowel syndrome (IBS) of both the constipation-dominant, diarrhea-dominant, and mixed form using the lactulose hydrogen breath test for orocecal transit time through the gut. Data are compared to those of healthy volunteers. The peak value of fermentation as read by hydrogen levels is captured after passage of the orocecal segment in the colon. Comparison are made between IBS patients and healthy subjects as regards orocecal transit time and peak fermentation in the cecum.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lactulose breath test

Trials testing the same drug.

NCT04705662 — GI Effects of Iron in Healthy Volunteers · NA · completed

Other Uppsala University trials

Trials by the same sponsor.

NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03141268 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uppsala University
Last refreshed: 9 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03141268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing